We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
RheEnergise is an energy company that plans to transform pumped hydro technology and boost its capacity with its patented High-Density Hydro (HDH) technology. The company asserts that, by installing HDH on smaller hills and combining it with its HD Fluid R-19, businesses could produce 2.5 times the energy compared to low-density pumped-hydro. RheEnergise aims to install multiple HDH projects to meet the UK's growing energy needs. The company has agreements with entities like SSE, WelshPower, GreenCat Renewables and REG-Power. It is currently using its funding grants of ~£270,000 over the next nine months to build a defendable "Moat" of IP (Patents, Design and copyrights, know-how, and trade secrets) across six critical integrated sub-systems. The company will use the investment received to hire key personnel, progress patents, and accelerate its activities.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £850,000
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £70,900
Emission Solutions (EMSOL) empowers organisations to take everyday steps to reduce emissions through their real-time emission monitoring and analytics system. EMSOL's open framework platform is built with networks of sensors like air and noise pollution, vehicle tracking, and working with any asset tags and emission sensors which enables EMSOL to perform real-time measurements with location tags and calibrated sensors. Data from these platforms are easily shared on dashboards, through notifications and gives detailed real-time data on urban noise, air quality, and vehicle pollution. To date, EMSOL won Rushlight Environmental Analysis Award, achieve yearly income targets, rated 5th place in the national PowerUp Index and 4th in the London and South East region. Moreover, EMSOL also won a fully funded project sponsored by DFT to deploy EMSOL technology into the rail sector. The company will use the funds to expand its customer base and increase the number of deployment sites.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £316,884
Over the past 8 years, Advatech Healthcare has created Hippo, a proven disabled and non-emergency patients transportation services (NEPTS) in the Essex area. Due to its dependability and efficiency, Hippo is now poised to become the UK's best national wheelchair accessible healthcare services on a wearable technology platform. According to the Office for Technology Statistics data, there are 13.37 million people disabled in the UK who lack dedicated non-emergency transportation. Hippo could save the National Health Service (NHS) up to 60% on transportation costs increasing faster hospital bed rotation and providing dedicated transportation for disabled and non-emergency patients with a medically trained staff. It also offers medical and technological necessities not offered by many leading operators. Currently, the company operates within the Essex area. By the end of 2020, the company aims to commence seven new contracts it has signed with the NHS. It also signed a deal with Cambridge Adult Social Care that is expected to close, within a 5-year term and generate over £200,000 per year.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Innovate Recycle (IR) is a company that aims to reduce carbon emissions from burning discarded carpets. It asserts that only 2% of the 400,000 tonnes of discarded carpets in the UK is recycled, with the rest going into a landfill or being incinerated. IR further points out that burning waste carpet leads to an estimated CO2 impact of £16 million per annum in the UK. It wants to solve this crisis. IR is building a new carpet recycling plant in Northamptonshire that would be able to recycle carpets into reusable materials. They have already received grant funding of up to £2.35 million. IR claims that a single production line in the plant, at full capacity, can recycle up to 20,000 tonnes each year and generate 12,600 tonnes of polypropylene pellets. It will use the investment to expand to a second production line by Year 4 at the same facility.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £2,650,000
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £148,736
Orbital Marine Power aims to harness the energy flowing in tidal streams and rivers through its award-winning tidal turbines. Orbital's O2 turbine is designed to deliver enough power for up to 2,000 homes. The company's vision is to focus on providing turbines and services into a future £20 billion per annum utility-scale global market for clean and predictable power from tidal streams. Orbital is currently providing £15 million of funded design projects to refine its IP protected low carbon tidal technology in readiness to scale up and play its part in meeting the ever-increasing demand for clean power. It will use the investment to grow its business across different verticals.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £2,595,231
Podcast Radio (PR) is the Ofcom-licensed UK digital broadcast radio station showcasing podcasts 24/7 globally. It is currently broadcasting in Surrey, Manchester, London, and Glasgow. Podcasting is expected to become a $3.3 billion industry by 2025. PR aims to be a disruptor in this segment. PR got front-page coverage in the international edition of Radio World magazine and has onboarded US radio Disc Jockey (DJ) Gene Baxter. The company will use 15% of the investment to secure digital radio broadcast transmission in 5 more UK cities by the end of 2020, 15% to partner with applicants for new digital radio transmitters, 15% to create a PR-led UK marketing campaign supported by social media, 25% to recruit new staff members, 10% to develop its on-air content, 10% to develop its website and application, and 10% to build new business partnerships to drive the international expansion of the company.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £149,023
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £522,689
Toraphene is an environmental technology company that aims to eliminate plastic waste. It has released with its product, Toraphene, to solve this crisis. It claims that Toraphene is a biodegradable, compostable and commercially-viable plastic packaging substitute for conventional plastic. The company asserts that its product is biodegradable even in the ocean, and has been developed using graphene technology. It is focussed on eliminating carrier bags and food containers in its first-round which account for 23% of marine waste. It aims to be a segment leader in the projected $25.4 billion biodegradable plastic industry by 2026. The company will use the investment to make Toraphene accessible to companies worldwide and make plastic packaging obsolete.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,000,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph